Notícias NGM Biopharmaceuticals Inc - NGM | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
NGM Biopharmaceuticals Inc (NGM)
NGM Biopharmaceuticals Inc (NGM) Notícias

NGM Biopharmaceuticals Inc (NGM)

1,54

0,00

(0,00%)

No fechamento: 04 Dezembro 6:00PM

Atrasado por 15 minutos

1,54

0,00

( 0,00% )

Após o horário de negociação: -

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

NGM Bio Announces Closing of Tender Offer

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

Form SC 13E3 - Going private transaction by certain issuers

Form SC 14D9 - Solicitation, recommendation statements

Form SC14D9C - Written communication relating to third party tender offer

Form 8-K - Current report

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

NGM Biopharmaceuticals

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições